Gland Pharma Limited has informed the Exchange regarding a press release dated July 29, 2026, titled "Gland Pharma receives approval for Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials".
Gland Pharma Ltd. Press Release Jul 29 2026
Earlier from Gland Pharma
- Press Release May 15 2026
- Press Release Mar 04 2026
- Press Release Feb 06 2026
- Press Release Jan 28 2026